Q-Linea
3.975 SEK +0.51%1 investor is following this company
Q-Linea is active in medical technology. The company specializes in the research and development of instruments and consumables. The products are mainly used in the treatment of infectious diseases and blood poisoning and include diagnostic and analysis tools, as well as other related basic sample handlings. The technology is based on the so-called ID and AST technology. The company was founded in 2008 and is headquartered in Uppsala.
Revenue
4.44M
EBIT %
-5,193.47 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
QLINEA
Daily low / high price
3.615 / 4.2
SEK
Market cap
465.74M SEK
Turnover
2.13M SEK
Volume
531K
Latest videos
Financial calendar
Interim report
11.07.2024
Interim report
31.10.2024
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Nexttobe AB | 53.5 % | 53.5 % |
Fjärde AP-fonden | 8.0 % | 8.0 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
BULLETIN FROM ANNUAL GENERAL MEETING IN Q-LINEA AB (PUBL)
Q-linea announces shipment of first IVD-marked ASTar® instrument to the US
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Q-linea receives another commercial order in Italy
![Q-Linea, Audiocast with teleconference, Q2'24](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/97f28477-7d54-4d91-a7b5-55f65631d866.png)
Q-Linea, Audiocast with teleconference, Q2'24
CMS proposes to approve the ASTar system for NTAP funding
Redeye: Q-linea Update - Commercial progress and financial challenges
![Q-Linea, Audiocast with teleconference, Q1'24](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/e211690f-4e6e-4f62-a2b6-b0f4b769e8ac.png)